Transenterix Inc. (TRXC) 2.86 $TRXC
TransEnterix, Inc. to Present at the RBC Capital Markets' 2015 Global Healthcare Conference
Business Wire - Thu Feb 12, 6:30AM CST
TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets' 2015 Global Healthcare Conference at the New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 2:05 p.m. Eastern Time on Wednesday, February 25, 2015.
TRXC: 2.86 (-0.11)
TransEnterix Schedules Fourth Quarter and Fiscal Year 2014 Financial and Operating Results Conference Call for February 24, 2015
Business Wire - Tue Feb 10, 4:03PM CST
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release fourth quarter and fiscal year 2014 financial and operating results before the market opens on Tuesday, February 24, 2015. Todd M. Pope, Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 8:30 am Eastern Time the same day. The call will be concurrently webcast.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. to Present at the 2015 Leerink Global Healthcare Conference
Business Wire - Thu Jan 29, 6:30AM CST
TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 2015 Leerink Global Healthcare Conference at The Waldorf Astoria Hotel in New York, New York. The presentation is scheduled to take place at 2:15 pm Eastern Time on Thursday, February 12, 2015.
TRXC: 2.86 (-0.11)
Intuitive Surgical Set To Regain Momentum In 2015
Stephen Simpson, CFA - at Seeking Alpha - Mon Jan 26, 12:00PM CST
ISRG: 510.73 (+3.02), JNJ: 99.62 (+1.18), COV: 106.71 (-1.36), TRXC: 2.86 (-0.11), SYK: 94.51 (+1.14)
Why Titan Is Even More Attractive Now Than It Was Prior To Delaying Its SPORT Unit
Point Of Return - at Seeking Alpha - Thu Jan 15, 8:05AM CST
ISRG: 510.73 (+3.02), TRXC: 2.86 (-0.11)
Notable Names In Securities Lending Last Week: NVGN, FRO
Interactive Brokers - at Seeking Alpha - Tue Jan 06, 1:35AM CST
As expected, trading activity was light last week given the market holiday and as many traders steered clear of the light volume characteristic of the final trading sessions of the year. Two names of note last week were Novogen Limited (NASDAQ: NVGN...
FRO: 2.96 (+0.07), GPRO: 45.27 (-0.02), HGSH: 3.05 (-0.13), NVGN: 2.79 (+0.17), CUBA: 8.68 (-0.13), JKS: 21.90 (+0.03), DO: 35.21 (+0.36), SCTY: 57.60 (+0.44), JCP: 8.05 (+0.14), CALA: 16.11 (+0.62), TRXC: 2.86 (-0.11), DGLY: 11.50 (-0.40)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 11:50AM CST
ADXS: 7.18 (+0.06), SANW: 4.80 (+0.19), ASPS: 22.32 (+0.09), OCN: 9.10 (+0.09), ZAZA: 2.17 (+0.08), SGOC: 0.56 (-0.03), AAMC: 173.53 (-8.22), VOC: 5.77 (+0.31), TECU: 3.07 (-0.02), RDUS: 50.37 (+0.63), IRMD: 14.61 (-0.35), SKYS: 10.55 (-0.65), VSCI: 0.47 (unch), CALA: 16.11 (+0.62), REXX: 5.08 (+0.13), CFRX: 4.00 (-0.06), TRXC: 2.86 (-0.11), CHNR: 1.91 (+0.01), CNET: 1.58 (+0.02), DRYS: 1.01 (+0.02)
TransEnterix perks up as patient-side robotic surgery system progresses
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 8:40AM CST
ISRG: 510.73 (+3.02), TRXC: 2.86 (-0.11)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 8:11AM CST
KMX: 67.68 (+1.10), MOLG: 2.46 (+0.03), CERS: 5.53 (+0.08), OREX: 5.55 (+0.10), APP: 0.92 (+0.04), ISIS: 63.86 (-0.43), PIR: 12.52 (+0.17), BBRY: 10.09 (+0.23), IMGN: 7.19 (unch), FMD: 5.45 (-0.16), RHT: 68.47 (+0.57), PETX: 16.52 (-0.10), NVGN: 2.79 (+0.17), TRXC: 2.86 (-0.11), NQ: 3.95 (-0.03), FINL: 23.51 (-0.32), TNK: 5.50 (+0.10)
TransEnterix Completes Successful Pre-Clinical Robotic Surgical Procedures; Management Affirms FDA Timeline
Business Wire - Fri Dec 19, 6:30AM CST
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the successful completion of four general surgery and urology procedures using its SurgiBot system patient-side robotic surgery system. Management also stated that the preparation of its FDA 510(k) filing is proceeding as planned, and affirmed prior guidance of its intention to submit the filing in mid-2015.
TRXC: 2.86 (-0.11)
TransEnterix elects Dr William N. Kelley to board
M2 - Fri Dec 12, 7:06AM CST
Medical device company TransEnterix (NYSE MKT:TRXC) disclosed on Thursday the addition of Dr William N. Kelley, MD to its board of directors.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. Appoints William N. Kelley, M.D. to Board of Directors
Business Wire - Thu Dec 11, 6:30AM CST
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the appointment of William N. Kelley, M.D. to serve on its Board of Directors. The appointment will be effective January 1, 2015, and increases the size of the TransEnterix Board of Directors to nine members. The Board of Directors determined that Dr. Kelley is an independent director.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. to Present at the 2014 Piper Jaffray Healthcare Conference
Business Wire - Wed Nov 19, 3:30PM CST
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 2014 Piper Jaffray Healthcare Conference at The New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 8:10 am Eastern Time on December 3, 2014.
TRXC: 2.86 (-0.11)
TransEnterix reports departure of COO Richard Mueller
M2 - Mon Nov 10, 7:46AM CST
TransEnterix (NYSE MKT:TRXC) disclosed on Friday that Richard Mueller has stepped down as its chief operating officer, with effect from 7 November 2014.
TRXC: 2.86 (-0.11)
TransEnterix COO quits
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:25PM CST
TRXC: 2.86 (-0.11)
TransEnterix, Inc. Reports Resignation of Chief Operating Officer
Business Wire - Fri Nov 07, 3:18PM CST
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that Richard Mueller, its Chief Operating Officer, resigned his position effective November 7, 2014.
TRXC: 2.86 (-0.11)
TransEnterix EPS in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:51AM CST
TRXC: 2.86 (-0.11)
TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2014
Business Wire - Thu Nov 06, 6:31AM CST
TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2014.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. to Present at the RBC Capital Markets' 2015 Global Healthcare Conference
Business Wire - Thu Feb 12, 6:30AM CST
TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the RBC Capital Markets' 2015 Global Healthcare Conference at the New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 2:05 p.m. Eastern Time on Wednesday, February 25, 2015.
TRXC: 2.86 (-0.11)
TransEnterix Schedules Fourth Quarter and Fiscal Year 2014 Financial and Operating Results Conference Call for February 24, 2015
Business Wire - Tue Feb 10, 4:03PM CST
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that it plans to release fourth quarter and fiscal year 2014 financial and operating results before the market opens on Tuesday, February 24, 2015. Todd M. Pope, Chief Executive Officer and Joseph P. Slattery, Executive Vice President and Chief Financial Officer will host a conference call to discuss these results starting at 8:30 am Eastern Time the same day. The call will be concurrently webcast.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. to Present at the 2015 Leerink Global Healthcare Conference
Business Wire - Thu Jan 29, 6:30AM CST
TransEnterix, Inc. (NYSE MKT:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 2015 Leerink Global Healthcare Conference at The Waldorf Astoria Hotel in New York, New York. The presentation is scheduled to take place at 2:15 pm Eastern Time on Thursday, February 12, 2015.
TRXC: 2.86 (-0.11)
Intuitive Surgical Set To Regain Momentum In 2015
Stephen Simpson, CFA - at Seeking Alpha - Mon Jan 26, 12:00PM CST
ISRG: 510.73 (+3.02), JNJ: 99.62 (+1.18), COV: 106.71 (-1.36), TRXC: 2.86 (-0.11), SYK: 94.51 (+1.14)
Why Titan Is Even More Attractive Now Than It Was Prior To Delaying Its SPORT Unit
Point Of Return - at Seeking Alpha - Thu Jan 15, 8:05AM CST
ISRG: 510.73 (+3.02), TRXC: 2.86 (-0.11)
Notable Names In Securities Lending Last Week: NVGN, FRO
Interactive Brokers - at Seeking Alpha - Tue Jan 06, 1:35AM CST
As expected, trading activity was light last week given the market holiday and as many traders steered clear of the light volume characteristic of the final trading sessions of the year. Two names of note last week were Novogen Limited (NASDAQ: NVGN...
FRO: 2.96 (+0.07), GPRO: 45.27 (-0.02), HGSH: 3.05 (-0.13), NVGN: 2.79 (+0.17), CUBA: 8.68 (-0.13), JKS: 21.90 (+0.03), DO: 35.21 (+0.36), SCTY: 57.60 (+0.44), JCP: 8.05 (+0.14), CALA: 16.11 (+0.62), TRXC: 2.86 (-0.11), DGLY: 11.50 (-0.40)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Dec 22, 11:50AM CST
ADXS: 7.18 (+0.06), SANW: 4.80 (+0.19), ASPS: 22.32 (+0.09), OCN: 9.10 (+0.09), ZAZA: 2.17 (+0.08), SGOC: 0.56 (-0.03), AAMC: 173.53 (-8.22), VOC: 5.77 (+0.31), TECU: 3.07 (-0.02), RDUS: 50.37 (+0.63), IRMD: 14.61 (-0.35), SKYS: 10.55 (-0.65), VSCI: 0.47 (unch), CALA: 16.11 (+0.62), REXX: 5.08 (+0.13), CFRX: 4.00 (-0.06), TRXC: 2.86 (-0.11), CHNR: 1.91 (+0.01), CNET: 1.58 (+0.02), DRYS: 1.01 (+0.02)
TransEnterix perks up as patient-side robotic surgery system progresses
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 8:40AM CST
ISRG: 510.73 (+3.02), TRXC: 2.86 (-0.11)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Dec 19, 8:11AM CST
KMX: 67.68 (+1.10), MOLG: 2.46 (+0.03), CERS: 5.53 (+0.08), OREX: 5.55 (+0.10), APP: 0.92 (+0.04), ISIS: 63.86 (-0.43), PIR: 12.52 (+0.17), BBRY: 10.09 (+0.23), IMGN: 7.19 (unch), FMD: 5.45 (-0.16), RHT: 68.47 (+0.57), PETX: 16.52 (-0.10), NVGN: 2.79 (+0.17), TRXC: 2.86 (-0.11), NQ: 3.95 (-0.03), FINL: 23.51 (-0.32), TNK: 5.50 (+0.10)
TransEnterix Completes Successful Pre-Clinical Robotic Surgical Procedures; Management Affirms FDA Timeline
Business Wire - Fri Dec 19, 6:30AM CST
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the successful completion of four general surgery and urology procedures using its SurgiBot system patient-side robotic surgery system. Management also stated that the preparation of its FDA 510(k) filing is proceeding as planned, and affirmed prior guidance of its intention to submit the filing in mid-2015.
TRXC: 2.86 (-0.11)
TransEnterix elects Dr William N. Kelley to board
M2 - Fri Dec 12, 7:06AM CST
Medical device company TransEnterix (NYSE MKT:TRXC) disclosed on Thursday the addition of Dr William N. Kelley, MD to its board of directors.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. Appoints William N. Kelley, M.D. to Board of Directors
Business Wire - Thu Dec 11, 6:30AM CST
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced the appointment of William N. Kelley, M.D. to serve on its Board of Directors. The appointment will be effective January 1, 2015, and increases the size of the TransEnterix Board of Directors to nine members. The Board of Directors determined that Dr. Kelley is an independent director.
TRXC: 2.86 (-0.11)
TransEnterix, Inc. to Present at the 2014 Piper Jaffray Healthcare Conference
Business Wire - Wed Nov 19, 3:30PM CST
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery, Executive Vice President and Chief Financial Officer, will present at the 2014 Piper Jaffray Healthcare Conference at The New York Palace Hotel in New York, New York. The presentation is scheduled to take place at 8:10 am Eastern Time on December 3, 2014.
TRXC: 2.86 (-0.11)
TransEnterix reports departure of COO Richard Mueller
M2 - Mon Nov 10, 7:46AM CST
TransEnterix (NYSE MKT:TRXC) disclosed on Friday that Richard Mueller has stepped down as its chief operating officer, with effect from 7 November 2014.
TRXC: 2.86 (-0.11)
TransEnterix COO quits
Seeking Alpha - at Seeking Alpha - Fri Nov 07, 3:25PM CST
TRXC: 2.86 (-0.11)
TransEnterix, Inc. Reports Resignation of Chief Operating Officer
Business Wire - Fri Nov 07, 3:18PM CST
TransEnterix, Inc. (NYSE MKT: TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced that Richard Mueller, its Chief Operating Officer, resigned his position effective November 7, 2014.
TRXC: 2.86 (-0.11)
TransEnterix EPS in-line
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 6:51AM CST
TRXC: 2.86 (-0.11)
TransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2014
Business Wire - Thu Nov 06, 6:31AM CST
TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics and flexible instruments to improve minimally invasive surgery, today announced its operating and financial results for the third quarter 2014.
TRXC: 2.86 (-0.11)
